reglab/statecodes huggingface dataset:
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 4 - PROFESSIONAL PRACTICES › Section R4-23-407 - Prescription Requirements

Current through Register Vol. 30, No. 28, July 12, 2024
A.
				Prescription orders. A pharmacist shall ensure that:
1. A prescription order the pharmacist uses
				to dispense a drug or device includes the following information:
a. Date of issuance;
b. Name and address of the patient for whom
				or the owner of the animal for which the drug or device is dispensed;
c. Drug name, strength, and dosage form or
				device name;
d. Name of the
				manufacturer or distributor of the drug or device if the prescription order is
				written generically or a substitution is made;
e. Prescribing medical practitioner's
				directions for use;
f. Date of
				dispensing;
g. Quantity prescribed
				and if different, quantity dispensed;
h. For a prescription order for a controlled
				substance, the medical practitioner's address and DEA number;
i. For a written prescription order, the
				medical practitioner's signature;
j. For an electronically transmitted
				prescription order, the medical practitioner's digital or electronic
				signature;
k. For an oral
				prescription order, the medical practitioner's name and telephone number;
				and
l. Name or initials of the
				dispensing pharmacist;
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 4 - PROFESSIONAL PRACTICES › Section R4-23-407.1 - Dispensing an Opioid Antagonist

Current through Register Vol. 30, No. 28, July 12, 2024
A. As used in this Section:
1. "Community member" means any person in
				position to assist an individual at risk of experiencing an opioid-related
				overdose. This includes emergency first responders, peace officers or other law
				enforcement personnel, fire department personnel, school district employees,
				and personnel of a facility or center that provides services to individuals at
				risk of experiencing an opioid-related overdose.
2. "Opioid antagonist" means any drug
				approved by the U.S. Food and Drug Administration that binds to opioid
				receptors, effectively blocking or inhibiting the receptor and preventing the
				body from responding to the opioid. Naloxone hydrochloride is an opioid
				antagonist.
3. "Opioid-related
				overdose" means an acute condition caused by excessive opioids. An
				opioid-related overdose can be identified by a triad of symptoms: decreased
				level of consciousness, pinpoint pupils, and respiratory depression. Other
				symptoms may include seizures, muscle spasms, and coma or death. An
				opioid-related overdose requires medical assistance.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 4 - PROFESSIONAL PRACTICES › Section R4-23-407.2 - Dispensing a Self-administered Hormonal Contraceptive

Current through Register Vol. 30, No. 28, July 12, 2024
A. Standard procedures. The first time a
				pharmacist dispenses a self-administered hormonal contraceptive under a
				standing prescription order, as authorized under A.R.S. § 32-1979.01, to a
				patient, the pharmacist shall:
1. Determine
				the patient is at least 18 years old;
2. Obtain from the patient a completed
				self-screening risk assessment based on nationally recognized
				guidelines;
3. Provide the patient
				with written information prepared by the manufacturer of the hormonal
				contraceptive; and
4. Provide the
				following information orally to the patient:
a. How hormonal contraception
				works;
b. When and how to take the
				self-administered hormonal contraceptive;
c. Risks associated with taking a
				self-administered hormonal contraceptive; and
d. When to seek medical assistance while
				taking a self-administered hormonal contraceptive.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 4 - PROFESSIONAL PRACTICES › Section R4-23-408 - Computer Records

Current through Register Vol. 30, No. 28, July 12, 2024
A. Systems
				manual. A pharmacy permittee or pharmacist-in-charge shall:
1. Develop, implement, and comply with
				policies and procedures for the following operational aspects of a computer
				system:
a. Examples of all output
				documentation provided by the computer system that contains original or refill
				prescription order or patient profile information;
b. Steps a pharmacy employee follows when the
				computer system is not operational due to scheduled or unscheduled system
				interruption;
c. Regular and
				routine backup file procedure and file maintenance, including secure storage of
				backup files;
d. Audit procedures,
				personnel code assignments, and personnel responsibilities; and
e. Quality assurance mechanism for data entry
				validation;
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 4 - PROFESSIONAL PRACTICES › Section R4-23-409 - Returning Drugs and Devices

Current through Register Vol. 30, No. 28, July 12, 2024
A.
				After a person for whom a drug is prescribed or the person's agent takes the
				drug from the premises where sold, distributed, or dispensed, a pharmacist or
				pharmacy permittee shall not accept the drug for return or exchange for the
				purpose of resale unless the pharmacist determines that:
1. The drug is in its original,
				manufacturer's, unopened container; and
2. The drug or its container has not been
				subjected to contamination or deterioration.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 4 - PROFESSIONAL PRACTICES › Section R4-23-410 - Current Good Compounding Practices

Current through Register Vol. 30, No. 28, July 12, 2024
A. This Section establishes the current good
				compounding practices to be used by a pharmacist licensed by the Board, in a
				pharmacy permitted by the Board, and in compliance with applicable federal and
				state law governing the practice of pharmacy.
B. A pharmacy permittee shall ensure
				compliance with the provisions in this subsection.
1. All substances for compounding that are
				received, stored, or used by the pharmacy permittee:
a. Meet official compendium
				requirements;
b. Are of high
				quality, such as Chemically Pure (CP), Analytical Reagent (AR), certified
				American Chemical Society (ACS), or Food Chemical Codex (FCC) grade;
				or
c. Are obtained from a source
				that, in the professional judgment of the pharmacist, is acceptable and
				reliable.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 4 - PROFESSIONAL PRACTICES › Section R4-23-411 - Pharmacist-administered or Intern-administered Immunizations

Current through Register Vol. 30, No. 28, July 12, 2024
A. Authorization to administer immunizations,
				vaccines, and emergency medications, as defined at A.R.S. §
									32-1974(N),
				to an eligible adult patient or eligible minor patient. As used in this
				Section, "eligible adult patient" means an eligible patient 13 years of age or
				older and "eligible minor patient" means an eligible patient at least three
				years of age but less than 13 years of age. A pharmacist or an intern in the
				presence of and under the immediate personal supervision of a pharmacist may
				administer, without a prescription, immunizations, vaccines, and emergency
				medications to an eligible adult patient or eligible minor patient, if:
1. Both the pharmacist and intern meet the
				qualifications and standards specified by A.R.S. §
										32-1974
				and this Section;
2. The Board
				authorizes both the pharmacist and intern as specified in subsection
				(D);
3. For an eligible adult
				patient, the immunization or vaccine is:
a.
				Recommended for adults by the United States Centers for Disease Control and
				Prevention; or
b. Recommended by
				the United States Centers for Disease Control and Prevention's Health
				Information for International Travel;
4. For an eligible adult patient, the
				immunization or vaccine is not on the Arizona Department of Health Services
				list specified in A.A.C.
				R9-6-1301
				as required under A.R.S. §
										32-1974(I);
5. For an eligible minor patient, the
				immunization or vaccine is for influenza or a booster dose as described under
				A.R.S. §
										32-1974(B)(2);
				and
6. For an eligible minor
				patient, any immunizations or vaccines other than influenza or a booster dose
				as described under A.R.S. §
										32-1974(B)(2)
				 are administered in response to a public
				health emergency declared by the Governor under A.R.S. §
										36-787.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 4 - PROFESSIONAL PRACTICES › Section R4-23-412 - Emergency Refill Prescription Dispensing

Current through Register Vol. 30, No. 28, July 12, 2024
A. When a state of emergency is declared
				under A.R.S. §
									32-1910(A)
				or (B) and the state of emergency results in
				individuals being unable to refill existing prescriptions, a pharmacist may
				work in the affected county, city, or town and may dispense a one-time
				emergency refill prescription of up to a 30-day supply of a prescribed
				medication to an affected individual if both of the following apply:
1. In the pharmacist's professional opinion
				the medication is essential to the maintenance of life or to the continuation
				of therapy, and
2. The pharmacist
				makes a good faith effort to reduce the information to a written prescription
				marked "emergency prescription" and files and maintains the prescription as
				required by law.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 4 - PROFESSIONAL PRACTICES › Section R4-23-413 - Temporary Recognition of Nonresident Licensure

Current through Register Vol. 30, No. 28, July 12, 2024
A. When a state of emergency is declared
				under A.R.S. §
									32-1910(A)
				or (B):
1.
				A pharmacist who is not licensed in this state, but who is currently licensed
				in another state, may dispense prescription medications in those affected
				counties, cities, or towns in this state during the time that a declared state
				of emergency exists under A.R.S. §
										32-1910(A)
				or (B) if both of the following apply:
a. The pharmacist provides proof of current
				licensure in another state, and
b.
				The pharmacist is engaged in a relief effort during a state of
				emergency.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 4 - PROFESSIONAL PRACTICES › Section R4-23-415 - Impaired Licensees - Treatment and Rehabilitation

Current through Register Vol. 30, No. 28, July 12, 2024
A. The Board may contract with qualified
				organizations to operate a program for the treatment and rehabilitation of
				licensees impaired as the result of alcohol or other drug abuse, pursuant to
				A.R.S. §
									32-1932.01.
B. Participants in the program are either
				"confidential" or "known." Confidential participants are self-referred and may
				remain unidentified to the Board, subject to maintaining compliance with their
				program contract. Known participants are under Board order to complete a
				minimum tenure in the program. After a known participant completes the minimum
				tenure, the Board may terminate the Board order and reinstate the participant's
				license to practice pharmacy.
C.
				The program contract with a qualified organization shall include as a minimum
				the following:
1. Duties and responsibilities
				of each party.
2. Duration, not to
				exceed two years, of contract and terms of compensation.
3. Quarterly reports from the program
				administrator to the Board indicating:
a.
				Identity of participants;
i. By name, if a
				known participant; or
ii. By case
				number, if a confidential participant;
b. Status of each participant, including;
i. Clinical findings;
ii. Diagnosis and treatment
				recommendations;
iii. Program
				activities; and
iv. General
				recovery and rehabilitation program information.
4. The program administrator shall
				report immediately to the Board the name of any impaired licensee who poses a
				danger to self or others.
5. The
				program administrator shall report to the Board, as soon as possible, the name
				of any impaired licensee:
a. Who refuses to
				submit to treatment,
b. Whose
				impairment is not substantially alleviated through treatment, or
c. Who violates the terms of their
				contract.
6. The program
				administrator shall periodically provide informational programs to the
				profession, including approved continuing education programs on the topic of
				drug and chemical impairment, treatment, and rehabilitation.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 5 - CONTROLLED SUBSTANCES PRESCRIPTION MONITORING PROGRAM › Section R4-23-501 - Controlled Substances Prescription Monitoring (CSPMP) Program Registration and Database Access

Current through Register Vol. 30, No. 28, July 12, 2024
A.Under A.R.S.
				§
									36-2606,
				a medical practitioner who is issued a license under A.R.S. Title 32, Chapter
				7, 11, 13, 14, 15, 16, 17, 21, 25, or 29 and possesses a current DEA
				registration under the Federal Controlled Substances Act shall have a current
				CSPMP registration issued by the Board.
B.Application.
1. An applicant for CSPMP registration shall:
a. Submit a completed application for CSPMP
				registration electronically or manually on a form furnished by the Board,
				and
b. Submit with the application
				form the documents specified in the application form.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 5 - CONTROLLED SUBSTANCES PRESCRIPTION MONITORING PROGRAM › Section R4-23-502 - Requirements for Data Format and Transmission

Current through Register Vol. 30, No. 28, July 12, 2024
A.Each dispenser shall submit to the Board or
				its designee by electronic means information regarding each prescription
				dispensed for a controlled substance listed in Schedules II, III, and IV of
				A.R.S. Title 36, Chapter 27, the Arizona Uniform Controlled Substances Act. The
				information reported shall conform to the August 31, 2005 Version 003, Release
				000 ASAP Rules-based Standard Implementation Guide for Prescription Monitoring
				Programs published by the American Society for Automation in Pharmacy as
				specified in A.R.S. §
									36-2608(B).
				The information submitted for each prescription shall include:
1. The name, address, telephone number,
				prescription number, and DEA registration number of the dispenser;
2. The name, address, gender, date of birth,
				and telephone number of the person or, if for an animal, the owner of the
				animal for whom the prescription is written;
3. The name, address, telephone number, and
				DEA registration number of the prescribing medical practitioner;
4. The quantity and National Drug Code (NDC)
				number of the Schedule II, III, or IV controlled substance dispensed;
5. The date the prescription was
				dispensed;
6. The number of
				refills, if any, authorized by the medical practitioner;
7. The date the prescription was
				issued;
8. The method of payment
				identified as cash or third party; and
9. Whether the prescription is new or a
				refill.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 5 - CONTROLLED SUBSTANCES PRESCRIPTION MONITORING PROGRAM › Section R4-23-503 - Access to Controlled Substances Prescription Monitoring Program Data

Current through Register Vol. 30, No. 28, July 12, 2024
A.Except as
				provided in A.R.S. §
									36-2604(B)
				and (C) and this Section, prescription
				information submitted to the Board or its designee is confidential and is not
				subject to public inspection.
B.The
				Board or its designee shall review the prescription information collected under
				A.R.S. Title 36, Chapter 28 and R4-23-502. If the Board or its designee has
				reason to believe an act of unprofessional or illegal conduct has occurred, the
				Board or its designee shall notify the appropriate professional licensing board
				or law enforcement or criminal justice agency and provide the prescription
				information required for an investigation.
C.The Board or its designee is authorized to
				release data collected by the program to the following:
1. A person who is authorized to prescribe or
				dispense a controlled substance to assist that person to provide medical or
				pharmaceutical care to a patient or to evaluate a patient;
2. An individual who requests the
				individual's own controlled substance prescription information under A.R.S.
				§
										12-2293;
3. A professional licensing board established
				under A.R.S. Title 32, Chapter 7, 11, 13, 14, 15, 16, 17, 18, 21, 25, or 29.
				Except as required under subsection (B), the Board or its designee shall
				provide this information only if the requesting board states in writing that
				the information is necessary for an open investigation or complaint;
4. A local, state, or federal law enforcement
				or criminal justice agency. Except as required under subsection (B), the Board
				or its designee shall provide this information only if the requesting agency
				states in writing that the information is necessary for an open investigation
				or complaint;
5. The Arizona Health
				Care Cost Containment System Administration regarding individuals who are
				receiving services under A.R.S. Title 36, Chapter 29. Except as required under
				subsection (B), the Board or its designee shall provide this information only
				if the Administration states in writing that the information is necessary for
				an open investigation or complaint;
6. A person serving a lawful order of a court
				of competent jurisdiction;
7. A
				person who is authorized to prescribe or dispense a controlled substance and
				who performs an evaluation on an individual under A.R.S. §
										23-1026;
				and
8. The Board staff for purposes
				of administration and enforcement of A.R.S. Title 36, Chapter 28 and this
				Article.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 5 - CONTROLLED SUBSTANCES PRESCRIPTION MONITORING PROGRAM › Section R4-23-504 - Computerized Central Database Tracking System Task Force

Current through Register Vol. 30, No. 28, July 12, 2024
A.The Board shall appoint a task force to
				help it administer the computerized central database tracking system as
				specified in A.R.S. §
									36-2603.
B.The Task Force shall meet at least once
				each year and at the call of the chairperson to establish the procedures and
				conditions relating to the release of prescription information specified in
				A.R.S. §
									36-2604
				and R4-23-503.
C.The Task Force
				shall determine:
1. The information to be
				screened;
2. The frequency and
				thresholds for screening; and
3.
				The parameters for using the information to notify medical practitioners,
				patients, and pharmacies to educate and provide for patient management and
				treatment options.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 5 - CONTROLLED SUBSTANCES PRESCRIPTION MONITORING PROGRAM › Section R4-23-505 - Reports

Current through Register Vol. 30, No. 28, July 12, 2024
A.Before releasing
				prescription monitoring program data, the Board or its designee shall receive a
				written or electronic request for controlled substance prescription
				information.
B.A person authorized
				to access CSPMP data under R4-23-503(C)(1) through (7) shall submit a written
				or electronic request that:
1. Specifies the
				information requested for the report;
2. For a medical practitioner, provides a
				statement that the report's purpose is to provide medical or pharmaceutical
				care to a patient or to evaluate a patient;
3. For an individual obtaining the
				individual's own controlled substance prescription information, provides a form
				of non-expired government-issued photo identification;
4. For a professional licensing board, states
				that the information is necessary for an open investigation or
				complaint;
5. For a local, state,
				or federal law enforcement or criminal justice agency, states that the
				information is necessary for an open investigation or complaint;
6. For the AHCCCS Administration, states that
				the information is necessary for an open investigation or complaint;
				and
7. For a person serving a
				lawful order of a court of competent jurisdiction, provides a copy of the court
				order.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-601 - General Provisions

Current through Register Vol. 30, No. 28, July 12, 2024
A. Permit
				required to sell a narcotic or other controlled substance, prescription-only
				drug or device, nonprescription drug, precursor chemical, or regulated
				chemical. A person shall have a current Board permit to:
1. Sell a narcotic or other controlled
				substance, prescription-only drug or device, nonprescription drug, precursor
				chemical, or regulated chemical in Arizona; or
2. Sell a narcotic or other controlled
				substance, prescription-only drug or device, nonprescription drug, precursor
				chemical, or regulated chemical from outside Arizona and ship the narcotic or
				other controlled substance, prescription-only drug or device, nonprescription
				drug, precursor chemical, or regulated chemical into Arizona.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-602 - Permit Application Process and Time Frames

Current through Register Vol. 30, No. 28, July 12, 2024
A.A person applying for a permit shall :
1. Submit a completed application for the
				desired permit electronically or manually on a form furnished by the Board,
				and
2. Submit with the application
				form:
a. The documents specified in the
				application form, and
b. The permit
				fee specified in
				R4-23-205.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-603 - Resident-Nonprescription Drugs, Retail

Current through Register Vol. 30, No. 28, July 12, 2024
A.Permit. A person, including the following,
				shall not sell or distribute a nonprescription drug without a current
				Board-issued permit:
1. A grocer;
2. Other non-pharmacy retail outlet;
				or
3. Mobile or non-fixed location
				retailer, such as a swap-meet vendor.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-604 - Resident Drug Manufacturer

Current through Register Vol. 30, No. 28, July 12, 2024
A.
				Permit. A person shall not manufacture, package, repackage, label, or relabel
				any narcotic or other controlled substance, prescription-only drug or device,
				nonprescription drug, precursor chemical, or regulated chemical without a
				current Board-issued drug manufacturer permit.
B. Application. To obtain a permit to operate
				a drug manufacturing firm in Arizona, a person shall submit a completed
				application, on a form furnished by the Board, and the fee specified in
				R4-23-205.
C. Before issuing a drug
				manufacturer permit, the Board shall:
1.
				Receive and approve a completed permit application;
2. Interview the applicant and manager, if
				different from the applicant, at a Board meeting; and
3. Receive a satisfactory compliance
				inspection report on the facility from a Board compliance officer.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-605 - Resident Drug Wholesaler Permit

Current through Register Vol. 30, No. 28, July 12, 2024
A.
				Permit. A person shall not operate a business or firm for the wholesale
				distribution of any drug, device, precursor chemical, or regulated chemical
				without a current Board-issued full-service or nonprescription drug wholesale
				permit.
B. Application.
1. To obtain a permit to operate a
				full-service or nonprescription drug wholesale firm in Arizona, a person shall
				submit a completed application, on a form furnished by the Board, and the fee
				specified in
				R4-23-205.
.
2. Before issuing
				a full-service or nonprescription drug wholesale permit, the Board shall:
a. Receive and approve a completed permit
				application;
b. Interview the
				applicant and the designated representative, if different from the applicant,
				at a Board meeting;
c. Receive a
				satisfactory compliance inspection report on the facility from a Board
				compliance officer; and
d. For a
				full-service drug wholesale permit, issue a fingerprint clearance to a
				qualified designated representative, as specified in subsection (L). If the
				fingerprint clearance of a designated representative for a full-service drug
				wholesale permit applicant is denied, the full-service drug wholesale permit
				applicant shall appoint another designated representative and submit the
				documentation, fingerprints, and fee specified in the application required in
				subsection (B).
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-606 - Resident-Pharmacy Permit: Community, Hospital, and Limited Service

Current through Register Vol. 30, No. 28, July 12, 2024
A.Permit. A person
				shall not operate a pharmacy in Arizona without a current Board-issued pharmacy
				permit.
B.Application.
1. To obtain a permit to operate a pharmacy
				in Arizona, a person shall submit a completed application, on a form available
				from the Board, and the fee specified in
				R4-23-205.
2. Before issuing a pharmacy permit, the
				Board shall:
a. Receive and approve a
				completed permit application; and
b. Receive a satisfactory compliance
				inspection report on the facility from a Board compliance officer.
3. Before issuing a pharmacy
				permit, the Board may interview the applicant and the pharmacist-in-charge, if
				different from the applicant, at a Board meeting based on the need for
				additional information.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-607 - Nonresident Permits

Current through Register Vol. 30, No. 28, July 12, 2024
A. Permit. A
				person that is not a resident of Arizona shall not sell or distribute any
				narcotic or other controlled substance, prescription-only drug or device,
				nonprescription drug, precursor chemical, or regulated chemical into Arizona
				without possessing both:
1. A current
				Board-issued nonresident pharmacy permit, nonresident manufacturer permit,
				nonresident full-service or nonprescription drug wholesale permit, or
				nonresident nonprescription drug permit; and
2. A current equivalent license or permit
				issued by the licensing authority in the jurisdiction where the person
				resides.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-608 - Change of Personnel and Responsibility

Current through Register Vol. 30, No. 28, July 12, 2024
A. A community, hospital, or limited-service
				pharmacy permittee shall give the Board:
1.
				Notice by mail, facsimile, or electronic mail within ten days of employing or
				terminating a pharmacist; and
2.
				Immediate notice of designating or terminating a
				pharmacist-in-charge.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-610 - Community Pharmacy Personnel and Security Procedures

Current through Register Vol. 30, No. 28, July 12, 2024
A. Every pharmacy shall have a pharmacist
				designated as the "pharmacist-in-charge."
1.
				The pharmacist-in-charge shall ensure the communication and compliance of Board
				directives to the management, other pharmacists, interns, and technicians of
				the pharmacy.
2. The
				pharmacist-in-charge shall:
a. Ensure that all
				pharmacy policies and procedures required under 4 A.A.C. 23 are prepared,
				implemented, and complied with;
b.
				Review biennially and, if necessary, revise all pharmacy policies and
				procedures required under 4 A.A.C. 23;
c. Document the review required under
				subsection (A)(2)(b);
d. Ensure
				that all pharmacy policies and procedures required under 4 A.A.C. 23 are
				assembled as a written or electronic manual; and
e. Make all pharmacy policies and procedures
				required under 4 A.A.C. 23 available in the pharmacy for employee reference and
				inspection by the Board or its staff.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-611 - Pharmacy Facilities

Current through Register Vol. 30, No. 28, July 12, 2024
A.
				Facilities. A pharmacy permittee or pharmacist-in-charge shall ensure that:
1. A pharmacy's facilities are constructed
				according to state and local laws and ordinances;
2. A pharmacy facility's:
a. Walls, ceilings, windows, floors, shelves,
				and equipment are clean and in good repair and order; and
b. Counters, shelves, aisles, and open spaces
				are not cluttered;
3.
				Adequate trash receptacles are provided and emptied periodically during the
				day;
4. A pharmacy facility of any
				pharmacy permit issued or pharmacy remodeled after February 1, 2014 provides
				access to toilet facilities either:
a. Within
				the pharmacy area, or
b. No further
				than a walking distance of 100 feet from the pharmacy area or an alternative
				distance approved by the Board or its designee;
5. The toilet facilities are maintained in a
				sanitary condition and in good repair;
6. All professional personnel and staff of
				the pharmacy keep themselves and their apparel clean while in the pharmacy
				area;
7. No animals, except
				licensed assistant animals and guard animals, are allowed in the
				pharmacy;
8. The pharmacy facility
				is kept free of insects and rodents; and
9. There is a sink with hot and cold running
				water, other than a sink in a toilet facility, within the pharmacy area for use
				in preparing drug products.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-612 - Equipment

Current through Register Vol. 30, No. 28, July 12, 2024
A pharmacy permittee or pharmacist-in-charge shall ensure
				  that a pharmacy has the necessary equipment to allow a pharmacist to practice
				  the profession of pharmacy, including the following:
1. Adequate refrigeration equipment dedicated
				to the storage of drugs and biologicals;
2. A C-V controlled substance register, if
				C-V controlled substances are sold without an order of a medical
				practitioner;
3. Graduates in
				assorted sizes;
4. One mortar and
				pestle, not required if the pharmacy permittee states in the application that
				compounding will not be performed in the pharmacy;
5. Spatulas of assorted sizes including one
				nonmetallic;
6. Prescription
				balance, Class A with weights or an electronic balance of equal or greater
				accuracy, not required if the pharmacy permittee states in the application that
				compounding will not be performed in the pharmacy;
7. One ointment tile or equivalent, not
				required if the pharmacy permittee states in the application that compounding
				will not be performed in the pharmacy
8. A current hard-copy or access to a current
				electronic-copy of the Arizona Pharmacy Act and administrative rules and
				Arizona Controlled Substance Act;
9. A professional reference library
				consisting of a minimum of one current reference or text, in hard-copy or
				electronic media, addressing the following subject areas:
a. Pharmacology or toxicology,
b. Therapeutics,
c. Drug compatibility, and
d. Drug product equivalency;
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-613 - Procedure for Discontinuing a Pharmacy

Current through Register Vol. 30, No. 28, July 12, 2024
A. A pharmacy permittee or
				pharmacist-in-charge shall provide written notice to the Board and the Drug
				Enforcement Administration (D.E.A.) at least 14 days before discontinuing
				operation of the pharmacy. The notice shall contain the following information:
1. Name, address, pharmacy permit number, and
				D.E.A. registration number of the pharmacy discontinuing business;
2. Name, address, pharmacy permit number (if
				applicable), and D.E.A. registration number (if applicable) of the licensee,
				permittee, or registrant to whom any narcotic or other controlled substance,
				prescription-only drug or device, nonprescription drug, precursor chemical, or
				regulated chemical will be sold or transferred;
3. Name and address of the location where the
				discontinuing pharmacy's records of purchase and disbursement of any narcotic
				or other controlled substance, prescription-only drug or device,
				nonprescription drug, precursor chemical, or regulated chemical will be kept
				and the person responsible for the records. These records shall be kept for a
				minimum of three years from the date the pharmacy is discontinued;
4. Name and address of the location where the
				discontinuing pharmacy's prescription files and patient profiles will be kept
				and the person responsible for the files and profiles. These records shall be
				kept for a minimum of seven years from the date the last original or refill
				prescription was dispensed; and
5.
				The proposed date of discontinuing business operations.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-614 - Automated Storage and Distribution System

Current through Register Vol. 30, No. 28, July 12, 2024
A. Before using an automated storage and
				distribution system, a pharmacy permittee or pharmacist-in-charge shall:
1. Ensure that the automated storage and
				distribution system and the policies and procedures comply with subsection (B);
				and
2. Notify the Board in writing
				of the intent to use an automated storage and distribution system, including
				the type or name of the system.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-615 - Mechanical Storage and Counting Device for a Drug in Solid, Oral Dosage Form

Current through Register Vol. 30, No. 28, July 12, 2024
A. A pharmacy
				permittee or pharmacist-in-charge shall ensure that a mechanical storage and
				counting device for a drug in a solid, oral dosage form that is used by a
				pharmacist or a pharmacy intern, graduate intern, pharmacy technician, or
				pharmacy technician trainee under the supervision of a pharmacist complies with
				the following method to identify the contents of the device:
1. The drug name and strength are affixed to
				the front of each cell or cassette of the device;
2. A paper or electronic log is kept for each
				cell or cassette that contains:
a. An
				identification of the cell or cassette by the drug name and strength or the
				number of the cell or cassette;
b.
				The drug's manufacturer or National Drug Code (NDC) number;
c. The expiration date and lot number from
				the manufacturer's stock bottle that is used to fill the cell or cassette. If
				multiple lot numbers of the same drug are added to a cell or cassette, each lot
				number and expiration date shall be documented, and the earliest expiration
				date shall become the expiration date of the mixed lot of drug in the cell or
				cassette;
d. The date the cell or
				cassette is filled;
e.
				Documentation of the identity of the licensee who placed the drug into the cell
				or cassette; and
f. If the licensee
				who filled the cell or cassette is not a pharmacist, documentation of the
				identity of the pharmacist who supervised the non-pharmacist licensee who
				filled the cell or cassette; and
3. The paper or electronic log is available
				in the pharmacy for inspection by the Board or its designee for not less than
				two years.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-616 - Mechanical Counting Device for a Drug in Solid, Oral Dosage Form

Current through Register Vol. 30, No. 28, July 12, 2024
A. A pharmacy
				permittee or pharmacist-in-charge shall ensure the accuracy of any mechanical
				counting device for a drug in a solid, oral dosage form that is used by a
				pharmacist or a pharmacy intern, graduate intern, pharmacy technician, or
				pharmacy technician trainee under the supervision of a pharmacist by
				documenting completion of the following:
1.
				Training in the maintenance, calibration, and use of the mechanical counting
				device for each employee who uses the mechanical counting device;
2. Maintenance and calibration of the
				mechanical counting device as recommended by the device's manufacturer;
				and
3. Routine quality assurance
				and accuracy validation testing for each mechanical counting device.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-617 - Temporary Pharmacy Facilities or Mobile Pharmacies

Current through Register Vol. 30, No. 28, July 12, 2024
A. Pharmacies located in declared disaster
				areas, nonresident pharmacies, and pharmacies licensed or permitted in another
				state but not licensed or permitted in this state, if necessary to provide
				pharmacy services during a declared state of emergency, may arrange to
				temporarily locate to a temporary pharmacy facility or mobile pharmacy or
				relocate to a temporary pharmacy facility or mobile pharmacy if the
				pharmacist-in-charge of the temporary pharmacy facility or mobile pharmacy
				ensures that:
1. The pharmacy is under the
				control and management of the pharmacist-in-charge or a supervising pharmacist
				designated by the pharmacist-in-charge;
2. The pharmacy is located within or adjacent
				to the declared disaster area;
3.
				The Board is notified of the pharmacy's location;
4. The pharmacy is properly secured to
				prevent theft and diversion of drugs;
5. The pharmacy's records are maintained in
				accordance with Arizona statutes and rules; and
6. The pharmacy stops providing pharmacy
				services when the declared state of emergency ends, unless it possesses a
				current resident pharmacy permit issued by the Board under A.R.S. §§
										32-1929,
				32-1930,
				and
				32-1931.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-620 - Continuous Quality Assurance Program

Current through Register Vol. 30, No. 28, July 12, 2024
A. Each pharmacy permittee shall implement or
				participate in a continuous quality assurance (CQA) program. A pharmacy
				permittee meets the requirements of this Section if it holds a current general,
				special or rural general hospital license from the Arizona Department of Health
				Services and is any of the following:
1.
				Certified by the Centers for Medicare and Medicaid Services to participate in
				the Medicare or Medicaid programs;
2. Accredited by the Joint Commission on the
				Accreditation of Healthcare Organizations; or
3. Accredited by the American Osteopathic
				Association.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-621 - Shared Services

Current through Register Vol. 30, No. 28, July 12, 2024
A. Before
				participating in shared services, a pharmacy shall have either a current
				resident or non-resident pharmacy permit issued by the Board.
B. A pharmacy may provide or utilize shared
				services functions only if the pharmacies involved:
1. Have the same owner, or
2. Have a written contract or agreement that
				outlines the services provided and the shared responsibilities of each party in
				complying with federal and state pharmacy statutes and rules, and
3. Share a common electronic file or
				technology that allows access to information necessary or required to perform
				shared services in conformance with the pharmacy act and the Board's
				rules.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-652 - Hospital Pharmacy Permit

Current through Register Vol. 30, No. 28, July 12, 2024
A. The
				following rules are applicable to all hospitals as defined by A.R.S. §
									32-1901
				and hospital pharmacies as defined by
				R4-23-651.
B. Before opening a hospital pharmacy, a
				person shall obtain a pharmacy permit as specified in
				R4-23-602
				and R4-23-606.
C. Discontinued
				hospitals. If a hospital license is discontinued by the state Department of
				Health Services, the pharmacy permittee or pharmacist-in-charge shall follow
				the procedures described in
				R4-23-613
				for discontinuing a pharmacy.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-653 - Personnel: Professional or Technician

Current through Register Vol. 30, No. 28, July 12, 2024
A. Each hospital pharmacy shall be directed
				by a pharmacist who is licensed to engage in the practice of pharmacy in
				Arizona and is referred to as the Director of Pharmacy. The Director of
				Pharmacy shall be the pharmacist-in-charge, as defined in A.R.S. §
									32-1901
				or shall appoint a pharmacist-in-charge. The Director of Pharmacy and the
				pharmacist-in-charge, if a different individual, shall:
1. Be responsible for all the activities of
				the hospital pharmacy and for meeting the requirements of the Arizona Pharmacy
				Act and these rules;
2. Ensure that
				the policies and procedures required by these rules are prepared, implemented,
				and complied with;
3. Review
				biennially and, if necessary, revise the policies and procedures required under
				these rules;
4. Document the review
				required under subsection (A)(3);
5. Assemble the policies and procedures as a
				written manual or by another method approved by the Board or its designee;
				and
6. Make the policies and
				procedures available within the pharmacy for employee reference and inspection
				by the Board or its designee.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-654 - Absence of Pharmacist

Current through Register Vol. 30, No. 28, July 12, 2024
A. If a
				pharmacist will not be on duty in the hospital, the Director of Pharmacy or
				pharmacist-in-charge shall arrange, before the pharmacist's absence, for the
				medical staff and other authorized personnel of the hospital to have access to
				drugs in the remote drug storage area defined in
				R4-23-110 or in the
				hospital pharmacy if a drug is not available in a remote drug storage area and
				is required to treat the immediate needs of a patient. A pharmacist shall be
				on-call during all absences.
B. If
				a pharmacist will not be on duty in the hospital pharmacy, the Director of
				Pharmacy or pharmacist-in-charge shall arrange, before the pharmacist's
				absence, for the medical staff and other authorized personnel of the hospital
				to have telephone access to an on-call pharmacist.
C. The hospital pharmacy permittee shall
				ensure that the hospital pharmacy is not without a pharmacist on duty in the
				hospital for more than 72 consecutive hours.
D. Remote drug storage area. The Director of
				Pharmacy or pharmacist-in-charge shall, in consultation with the appropriate
				committee of the hospital:
1. Develop and
				maintain an inventory listing of the drugs to be included in a remote drug
				storage area; and
2. Develop,
				implement, review, and revise in the same manner described in
				R4-23-653(A)
				and comply with policies and procedures that ensure proper storage, access, and
				accountability for drugs in a remote drug storage area.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-655 - Physical Facility

Current through Register Vol. 30, No. 28, July 12, 2024
A. General. A
				hospital pharmacy permittee shall ensure that the hospital pharmacy has
				sufficient equipment and physical facilities for proper compounding,
				dispensing, and storage of drugs, including parenteral preparations.
B. Minimum area of hospital pharmacy. The
				minimum area of a hospital pharmacy depends on the type of hospital, the number
				of beds, and the pharmaceutical services provided. Any hospital pharmacy permit
				issued or hospital pharmacy remodeled after January 31, 2003 shall provide a
				minimum hospital pharmacy area, the actual area primarily devoted to drug
				dispensing and preparation functions, exclusive of bulk drug storage, satellite
				pharmacy, and office areas that is not less than 500 square feet. The minimum
				area requirement, not including unusable area, may be varied upon approval by
				the Board for out-of-the-ordinary conditions or for systems that require less
				space.
C. The Board may also
				require that a hospital pharmacy permittee or applicant provide:
1. More than the minimum area if equipment,
				inventory, personnel, or other factors cause crowding to a degree that
				interferes with safe pharmacy practice;
2. Additional dispensing, preparation, or
				storage areas because of the increased number of specific drugs prescribed per
				day, the increased use of intravenous and irrigating solutions, and the
				increased use of disposable and prepackaged products;
3. Additional dispensing, preparation, or
				storage areas to handle investigational drugs, emergency drug kits,
				chemotherapeutics, alcohol and other flammables, poisons, external
				preparations, and radioisotopes, and to accommodate quality control procedures;
				and
4. Additional office space to
				provide for an increased number of personnel, a drug information library, a
				poison information library, research support, teaching and conferences, and a
				waiting area.
Arizona Administrative Code › Title 4 - PROFESSIONS AND OCCUPATIONS › Chapter 23 - BOARD OF PHARMACY › Article 6 - PERMITS AND DISTRIBUTION OF DRUGS › Section R4-23-656 - Sanitation and Equipment

Current through Register Vol. 30, No. 28, July 12, 2024
A hospital pharmacy permittee or Director of Pharmacy shall
				  ensure that a hospital pharmacy:
1.
				Has a professional reference library consisting of hard-copy or electronic
				media appropriate for the scope of pharmacy services provided by the
				hospital;
2. Has a sink, other than
				a sink in a toilet facility, that:
a. Has hot
				and cold running water;
b. Is
				within the hospital pharmacy area for use in preparing drug products;
				and
c. Is maintained in a sanitary
				condition and in good repair;